Is there a medical need to explore the clinical use of insulin-like growth factor I? (Q34349473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Is there a medical need to explore the clinical use of insulin-like growth factor I? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

6

R G Rosenfeld

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

M O Savage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Cecilia Camacho-Hübner

series ordinal

2

object named as

C Camacho-Hübner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M B Ranke

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R J Ross

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

Growth Hormone & I G F Research

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

11 Suppl A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

S65-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Acquired growth hormone resistance in catabolic states

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I).

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Growth hormone and IGF-I therapy in the hypercatabolic patient

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Obesity: a rational target for managing diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980011-3

7 January 2021

10.1016/S1096-6374(01)80011-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11527091%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference